Cargando…
Biomarkers of pulmonary hypertension in patients with scleroderma: a case–control study
INTRODUCTION: Significant pulmonary vascular disease is a leading cause of death in patients with scleroderma, and early detection and early medical intervention are important, as they may delay disease progression and improve survival and quality of life. Although several biomarkers have been propo...
Autores principales: | McMahan, Zsuzsanna, Schoenhoff, Florian, Van Eyk, Jennifer E., Wigley, Fredrick M., Hummers, Laura K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527208/ https://www.ncbi.nlm.nih.gov/pubmed/26245195 http://dx.doi.org/10.1186/s13075-015-0712-4 |
Ejemplares similares
-
Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis
por: Dein, Eric J., et al.
Publicado: (2021) -
Long Term Effects of Cyclophosphamide Treatment on Lung Function and Survival in Scleroderma Patients with Interstitial Lung Disease
por: Mittoo, S, et al.
Publicado: (2011) -
Paclitaxel Modulates TGFβ Signaling in Scleroderma Skin Grafts in Immunodeficient Mice
por: Liu, Xialin, et al.
Publicado: (2005) -
Race and Association With Disease Manifestations and Mortality in Scleroderma: A 20-Year Experience at the Johns Hopkins Scleroderma Center and Review of the Literature
por: Gelber, Allan C., et al.
Publicado: (2013) -
Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
por: Wallwork, Rachel, et al.
Publicado: (2022)